It was a very busy week for the Contemporary OB/GYN® team.
This week’s top articles included:
Curbside Consults delivers expert perspectives from physicians outside of the ob/gyn specialty to provide insight into various health issues affecting pregnant women, about which they are experts. This new section is the brainchild of Editorial Advisory Board member Christine Isaacs, MD.
Elizebeth Harmon, MD, MBA, FACOG shares her thoughts on an article from Contemporary OB/GYN®'s November issue.
Being named in a lawsuit does not always mean a medical error was made. Most claims are dropped, dismissed, or withdrawn, and trials are often won by the physician. Take a look back at the year’s top cases and see how each one unfolded.
A study in the journal Vascular Health and Risk Management has found significant differences in the metabolite profiling of altered amino acid and lipoprotein metabolism in participants with atherosclerosis and osteoporosis, compared with those in healthy menopausal women.
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More